In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma (Q40076011)

17 September 2017

title

In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma (English)

1 reference

17 September 2017

Maka Burjanadzé

1

1 reference

17 September 2017

Maud Condomines

2

1 reference

17 September 2017

Thierry Reme

3

1 reference

17 September 2017

Philippe Quittet

4

1 reference

17 September 2017

Pascal Latry

5

1 reference

17 September 2017

Cécile Lugagne

6

1 reference

17 September 2017

François Romagne

7

1 reference

17 September 2017

Yanis Morel

8

1 reference

17 September 2017

Jean François Rossi

9

1 reference

17 September 2017

Bernard Klein

10

1 reference

17 September 2017

Zhao Yang Lu

11

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

British Journal of Haematology

17 September 2017

published in

1 reference

17 September 2017

volume

139

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

206-216

1 reference

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Lentiviral transduction of primary myeloma cells with CD80 and CD154 generates antimyeloma effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Activation of V gamma 9V delta 2 T cells by NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Alkylamines cause Vgamma9Vdelta2 T-cell activation and proliferation by inhibiting the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Gammadelta T cells for immune therapy of patients with lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06754.X

10.1111/J.1365-2141.2007.06754.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference